Drug Delivery

Oct 26, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
Parteck SRP 80 is a functional excipient designed for sustained-release matrix tablets.
Oct 08, 2015
PTSM: Pharmaceutical Technology Sourcing and Management
By Pharmaceutical Technology Editors
A collaboration between Grace and Formac Pharmaceuticals results in drug delivery option for poorly-soluble APIs.
Oct 06, 2015
By Pharmaceutical Technology Editors
3M and Impel will collaborate to develop and commercialize Impel’s Precision Olfactory Delivery technology for enhanced central nervous system drug delivery.
Oct 02, 2015
Pharmaceutical Technology
New formulations that enhance bioavailability, optimize drug-delivery profiles, reduce dosing frequency, or improve patient experience have the potential to deliver quicker returns on investments than developing a completely new drug.
Oct 02, 2015
Pharmaceutical Technology
This article looks at the current status of alcohol-induced dose dumping of modified-release formulations and the need for regulatory harmonization in handling this challenge.
Sep 25, 2015
There is growing interest in the development of liquid formulations in prefilled syringes and autoinjectors, which offer convenience and ease of administration in a home setting.
Sep 21, 2015
By Pharmaceutical Technology Editors
The company will showcase its range of drug packaging and delivery systems as well as launch a new ready-to-use validated packaging component.
Sep 18, 2015
By Pharmaceutical Technology Editors
West Pharmaceutical Services and HealthPrize Technologies are collaborating on self-reporting and bar coding capabilities for injectable drug-delivery systems.
Sep 08, 2015
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Tuzistra XR for cough relief is said to be the only twice-daily, extended-release codeine-based cough and cold syrup available in the US.
Sep 02, 2015
Pharmaceutical Technology
Current guidance for absorption of elemental impurities does not address dermal exposure, resulting in a simplistic approach to limit setting; available information shows that exposure to low-level elemental impurities is unlikely to be a substantive concern for topical drug products.
native1_300x100
lorem ipsum